Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Goldman Sachs Group (NY:GS)

1,090.67 +14.50 (+1.35%)
Official Closing Price Updated: 4:10 PM EDT, Jun 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Goldman Sachs Group

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Altimmune Sets Pemvidutide’s Phase 3 MASH Playbook as AUD Data Near ↗
Altimmune (NASDAQ:ALT) management used an appearance at the Goldman Sachs Global Healthcare Conference to outline the company’s focus on pemvidutide, its lead metabolic and liver disease drug... 
Via MarketBeat
News headline image
The Grandest Castle Ever Floated (and the Stocks to Profit From It) ↗
The SpaceX IPO has Wall Street debating trillion-dollar valuations. Luke Lango argues the selloff it triggered is actually the buying opportunity investors have been waiting for in Corning, Ciena,... 
Via InvestorPlace
Topics Artificial Intelligence Initial Public Offering
News headline image
LinkedIn's New Creator Marketplace Could Reshape the Global Creator Economy
 
Via PR Leap
Topics Artificial Intelligence Economy
News headline image
Is Walmart a Millionaire-Maker Stock? ↗
What comes next for the iconic big box retailer? 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
CG Oncology Eyes Bladder Cancer Breakthrough With Phase 3 Data, Q4 Filing Ahead ↗
CG Oncology (NASDAQ:CGON) Chief Executive Officer Arthur outlined the company’s upcoming clinical and regulatory milestones for cretostimogene during a presentation at the Goldman Sachs Global... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Why Signet Jewelers Stock Triumphed on Tuesday ↗
It announced a $50 million accelerated share repurchase program. 
Via The Motley Fool
News headline image
The SpaceX IPO Is Days Away. Here's How to Prepare. ↗
SpaceX is hoping to raise $75 billion at a $1.77 trillion valuation. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Goldman Sachs Just Made a Bold Statement About SpaceX. Here's Why I'm Not Buying It ↗
Things would have to go perfectly for the next half-decade. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Expro, NESR, and Nabors Industries Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after Trump said a US-Iran deal could come in "two or three days," pulling energy equities sh... 
Via StockStory
Topics Government
Tuesday's session: top gainers and losers in the dow jones index ↗
Via Chartmill
News headline image
Amneal Pharmaceuticals Bets on Biosimilars, Patches to Power Next Growth Phase ↗
Amneal Pharmaceuticals (NASDAQ:AMRX) Co-Founder, President and Co-Chief Executive Officer Chirag Patel said the company is entering a stronger growth phase, driven by momentum in its existing generics... 
Via MarketBeat
News headline image
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts ↗
Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst... 
Via MarketBeat
Stay informed with the top movers within the dow jones index on Tuesday. ↗
Via Chartmill
News headline image
Option Care Health (OPCH) Stock Trades Up, Here Is Why
What Happened? Shares of alternate site health provider Option Care Health (NASDAQ:OPCH) jumped 3.7% in the morning session after Goldman Sachs initiated cov... 
Via StockStory
News headline image
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure ↗
Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for... 
Via MarketBeat
Topics ETFs Intellectual Property
Citi, Goldman Stay Bullish on Copper Amid Ongoing Supply Pressures
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
Annexon Eyes ‘Win Season’ With Q4 Vision Trial Data, GBS Filings Ahead ↗
Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the... 
Via MarketBeat
From SaaS to AaaS: How Tec-Do's Multi-Agent Infrastructure is Shaping the Future of MarTech
Via GlobePRwire
Topics Artificial Intelligence ETFs
News headline image
GS Stock Trades Near $1,045 After June 2026 Market Session ↗
Goldman Sachs stayed in focus as GS stock traded near $1,045 on June 9, 2026, after another active market session. The stock was recently priced at $1,045. 
Via Talk Markets
Topics Earnings
News headline image
Prediction: June 12 Will be a Huge Day for the Stock Market ↗
Investors are being offered a new AI investment opportunity. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Bioventus Highlights PNS, PRP Growth as Cash Flow Improves and Debt Falls ↗
Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering... 
Via MarketBeat
Topics Initial Public Offering
News headline image
Could Investing in the SpaceX IPO Set You Up for Life? History Offers an Answer That's Crystal Clear. ↗
SpaceX says it may serve a $28 trillion market. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Why Is Oscar Health (OSCR) Stock Rocketing Higher Today
What Happened? Shares of health insurance company Oscar Health (NYSE:OSCR) jumped 10.8% in the afternoon session after the company provided a business update... 
Via StockStory
Topics Artificial Intelligence
Exploring the top movers within the dow jones index during today's session. ↗
Via Chartmill
News headline image
Nasdaq and S&P 500 Bounce Back On Monday as Chip Stocks Shake Off Friday's Hangover ↗
Semiconductor stocks are staging a comeback on Monday. Here's what's driving the rebound in Intel, Micron, and the broader market. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
Assembly Biosciences Teases Gilead HSV-2 Decision, Liver Disease Data Ahead ↗
Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming... 
Via MarketBeat
Uncover the latest developments among dow jones stocks in today's session. ↗
Via Chartmill
News headline image
VOO vs. RSP: Which S&P 500 ETF Is Better? ↗
Choosing between these two S&P 500 ETFs really comes down to how you feel about the tech sector. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Why Peloton Stock Zoomed More Than 17% Higher Last Month ↗
It flipped into the black on the bottom line in its latest reported quarter. 
Via The Motley Fool
News headline image
Is VEA the Smartest Investment You Can Make Right Now? ↗
Your best long-term investment may not include U.S. stocks. 
Via The Motley Fool
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.